From new outcomes of paclitaxel-coated devices to DCB use below the knee, the CX Peripheral Executive Board looks ahead to CX 2019 and raises some of the key questions that will be addressed in the programme.
CX 2019 Peripheral Challenges Programme Highlights
CX 2023: Aortic Techniques & Technologies Highlights
March 6th, 2023 | 0 Comments
CX 2023: Andrew Bradbury discusses BASIL-2 trial
March 1st, 2023 | 0 Comments
CX 2023: Reaching Peripheral Arterial Consensus with a World-Class Faculty
January 3rd, 2023 | 0 Comments